Skip to main content
. 2022 Jul 22;2022(7):CD008080. doi: 10.1002/14651858.CD008080.pub2

3.3. Analysis.

3.3

Comparison 3: Intratympanic corticosteroids compared to no treatment/placebo as secondary therapy, Outcome 3: Final PTA